The geniposide-phospholipid complex reduces levels of inflammatory cytokines (TNF-α, IL-6, and IL-1β) in hyperuricemic mice and regulates the PI3K/AKT/NF-κB signaling cascade to improve post-hyperuricemia chronic kidney disease (Wang et al., 2022a). Here, IL1B is linked to hyperuricemia.